Trombosis venosa cerebral e hipertensión endocraneana
Main Article Content
Abstract
La trombosis venosa cerebral (TVC) es una forma poco frecuente de accidente cerebrovascular con una baja tasa de mortalidad. A partir de un caso clínico de una paciente con TVC e hipertensión endocraneana severa, realizamos una revisión a través de una búsqueda bibliográfica acerca de las características de esta entidad haciendo especial hincapié en las opciones terapéuticas. La sintomatología de esta patología varía desde cefalea aislada hasta el coma, y para el diagnóstico contamos con TC o RMN asociado a venografía cerebral. Se recomienda fuertemente la anticoagulación, mientras que la trombolisis y la craniectomía descompresiva serían una opción en grupos con mala evolución. La falta de evidencia sólida, pone al médico tratante en la difícil tarea de decidir qué camino tomar ante un paciente con este diagnóstico. El monitoreo neurológico y la prevención de la trombosis conforman los pilares para obtener una evolución neurológica favorable.
Article Details
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.
References
1. Bousser MG, Ferro JM: Cerebral venous thrombosis: an update. Lancet Neurology 6:162– 170, 2007
2. Einhäupl K, , J. Stamb, M. -G. Bousser et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. European Journal of Neurology 2010, 17: 1229–1235
3. Saposnik, G, Barinagarrementeria F, Brown R, Jr et al. Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:1158–92.
4. Ferro JM, Canhão P, Stam J, et al. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) Stroke 2004;35;664-670;
5. Cerobrovascular Disease. 2009. Kaplan, Chapter 16. Cerebral Venous Thrombosis. 554-577
6. Aaron S, Alexander M, Maya T, et al. Underlying prothrombotic states in pregnancy associated cerebral venous thrombosis. Neurology India | Jul-Aug 2010 | Vol 58 | Issue 4
7. Ferro JM, Lopes MG. VENOPORT. Delay in hospital admision of patients with cerebral vein and dural sinus thrombosis Cerebrovas Dis 2005,19:152-156
8. Stam J: Thrombosis of the cerebral veins and sinuses. N Engl J Med 352:1791–1798, 2005
9. Ferro JM, Canhao P, Stam J, et al. Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke 2009; 40: 3133-3138
10. Masuhr F, Mehraein S, Einhäupl K: Cerebral venous and sinusthrombosis. J Neurol 251:11–23, 2004
11. Provenzale J, Kranz P. Dural Sinus Thrombosis: Sources of Error in Image Interpretation. Neuroradiology AJR 2011; 196: 23-31
12. Giraldo E, Petrinjac, Nenadic R, The ‘‘Cord Sign’’ in Cerebral Venous Thrombosis Associated with High Plasma Levels of Factor VIII. Neurocritical Care DOI 10.1007/s12028-2010-9434-2
13. Liauw L, van Buchem MA, Spilt A, de Bruine FT, van den Berg R, Hermans J, et al. MR
angiography of the intracraneal venous system. Radiology. 2000;214:678—82
14. Canho P, Ferro JM, Lindgren A, Causes and predictors of Death in Cerebral
Venous Thrombosis. Stroke 2005,36;1720-1725
15. Preter M, Tzourio CH, Ameri A, Bousser MG. Long term prognosis in cerebral venous thrombosis: a follow-up of 77 patients. Stroke. 1996;27:243–246.
16. de Bruijn SFTM, de Haan RJ, Stam J, for the Cerebral Venous Sinus Thrombosis Study Group. Clinical features and prognostic factors ofcerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry. 2001;70:105–108.
17. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J, for the Cerebral Venous Thrombosis Portuguese Collaborative Study Group (VENOPORT). Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT Study. Cerebrovasc Dis. 2002;13:272–278.
18. Ferro JM, Canha˜o P, Complications of Cerebral Vein and Sinus Thrombosis . Handbook on Cerebral Venous Thrombosis. Front Neurol Neurosci. Basel, Karger, 2008, vol 23, pp 161–171
19. Lamy C, Hamon JB, Costa J, Mas JL, for the French Study Group on Stroke in Pregnancy. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. Neurology. 2000;55:269–274.
20. Farrag A, Irfan M, Guliani G; et al. Occurrence of Post-Acute Recanalization and Collateral Formation in Patients with Cerebral Venous and Sinus Thrombosis. A Serial Venographic Study. Neurocrit Care DOI 10.1007/s12028-010-9394-6.
21. Einha¨ upl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991; 338: 597–600.
22. De Bruijn SFTM, Stam J, for the Cerebral Venous Sinus Thrombosis Study Group. Randomized, placebo controlled trial of anticoagulant treatment with lowmolecular-weight heparin for cerebral sinus thrombosis. Stroke 1999; 30: 484–488.
23. Stam J, de Bruijn SFTM, deVeber G. Anticoagulation for cerebral sinus thrombosis. The Cochrane Database of Systematic Reviews Issue 4. 2001: Art. No.: CD002005.
24. Coutinho J, de Bruijn SFTM, deVeber G, Stam J. Anticoagulation for cerebral venous sinus thrombosis (Review). The Cochrane Collaboration. Published in The Cochrane Library2011, Issue 8
25. Girot M, Ferro JM, Canhão P, et al.: ISCVT Investigators: Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007, 38:337–342.
26. Ferro JM and Canhao P. Acute Treatment of Cerebral Venous and Dural Sinus Thrombosis. Current Treatment Options in Neurology 2008, 10:126–137
27. Fuentes B, Martinez-Sanchez P, García Raya P, Abenza MJ, Diez Tejedor E. Cerebral Venous Sinus Thrombosis Associated With Cerebral Hemorrhage. Is Anticoagulant Treatment Safe? The Neurologist 2011;17:208–210.
28. Coutinho J, Ferro JM, Canhao P, et al. Unfractined or Low Molecular Weight Heparin for the Treatment of Cerebral Venous Thrombosis. Stroke 2010; 41: 2575-2580.
29. Van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. The Cochrane Database of Systematic Reviews Issue 4. 2004: Art. No.: CD001100.
30.. Dentali F, Squizzato A, Gianni M et al. Safety of thrombolissys in cerebral venous thrombosis. A systematic review of the literature. Thromb Haemost 2010; 104
31. Einha¨ upl KM, Masuhr F. Cerebral venous and sinus thrombosis – an update. Eur J Neurol 1994; 1: 109–126.
32. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992; 10: 87–111.
33. Ferro JM, Canha˜o P, Bousser MG, Stam J, Barinagarrementeria F, for the ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 2008; 39: 1152–1158.
34. Canha˜o P, Cortesa˜o A, Cabral M, et al., for the ISCVT Investigators Are steroids useful to treat cerebral venous thrombosis? Stroke 2008; 39: 105–110.
35. The´audin M; Crassard I, ; Bresson D, et al. Should Decompressive Surgery Be Performed in Malignant Cerebral Venous Thrombosis? Stroke. 2010;41:727-731.
36. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, et al. DECIMAL, DESTINY, and HAMLET investigators Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–222.
37. Ferro JM, Crassard I, Coutinho JM, et al. Decompressive Surgery in Cerebrovenous Thrombosis : A Multicenter Registry and a Systematic Review of Individual Patient Data. Stroke 2011, 42:2825-2831:
38. Mohindra S, Umredkar A, Navneet S, Bal A and Gupta S. Decompressive craniectomy for malignant cerebral oedema of cortical venous thrombosis: an analysis of 13 patients. British Journal of Neurosurgery, June 2011; 25(3): 422–429